The grant will provide up to $2.1 million to support the development of gel embolic material for transcatheter embolization.
Category: Startup News
Suono Bio, Inc. Announces Oversubscribed Series A Funding Round
Suono Bio will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
3D printed DNA-coated ‘ChemoFilters’ unlock targeted cancer therapy
The devices can be injected into patients during intra-arterial chemotherapy, to drain affected organs and prevent toxic agents from entering their bloodstream.
Alio Raises $20M in Series B Financing
“This funding provides us with the resources to advance key clinical programs and partnerships assessing remote monitoring benefits for chronic kidney disease and dialysis patients.”
NeuraLace ties up FDA clearance for chronic pain-relieving nerve stimulation device
The system emits subtle magnetic pulses through the skin to stimulate peripheral nerve cells that are responsible for relieving pain, but that have been damaged in patients with chronic pain.
Mobility-Enabled Compression Device for Lymphedema: Interview with CEO of Koya Medical
Koya’s Dayspring is the first wearable and mobility-enabled compression solution for lymphedema designed with real life in mind.
CloudCath Announces Collaboration with American Renal Associates in Pre-Market Clinical Study for Peritoneal Dialysis Patients
Innovative Remote Monitoring Platform Will Be Tested for In-Home Use
Emme, smart birth control case company, launches telemedicine service
The new expansion, known as EmmeRx, means patients in 16 states will be able to get contraception prescribed and delivered.
First Patient Treated in Landmark U.S. Randomized Clinical Trial of NeuraLace’s Chronic Pain Treatment
Study to Evaluate the Efficacy and Economic Benefit of Axon Therapy® Designed to Relieve Pain and Improve Quality of Life Compared with Conventional Medical Management.
Oncodisc Inc. Acquired by PAVmed Digital Health Company Veris Health Inc.
Oncodisc To Combine With PAVmed Subsidiary Veris Health To Advance Development Of Next-Generation Intelligent Implantable Remote Care Technology Initially Benefitting 17 Million Annual Global Cancer Patients